Sector: MedicalEnzon Pharmaceuticals, Inc. (NASDAQ: ENZN)
Headlines
- Enzon Opens Pediatric Study of PEG-SN38
Feb 24, 2010 08:30 AM | ENZN
- Enzon Board of Directors Appoints Executive Committee
Feb 22, 2010 07:37 AM | ENZN
- Enzon Reports 2009 Results
Feb 17, 2010 08:31 AM | ENZN
- CORRECTING and REPLACING Enzon to Release Fourth Quarter 2009 Earnings on Wednesday, February 17, 2010; Conference Call and Webcast to Follow
Feb 09, 2010 11:23 AM | ENZN
- Enzon to Release Fourth Quarter 2009 Earnings on Wednesday, February 17, 2010; Conference Call and Webcast to Follow
Feb 09, 2010 10:06 AM | ENZN
- Enzon Stockholders Approve Sale of Specialty Pharmaceutical Business
Jan 27, 2010 04:00 PM | ENZN
- Enzon Opens a Phase 2 Study of PEG-SN38 for Metastatic Breast Cancer
Jan 06, 2010 08:48 AM | ENZN
- Enzon Presents Data at 2009 EORTC Meeting
Nov 19, 2009 09:19 AM | ENZN
- Enzon to Present Data at EORTC-NCI-AACR
Nov 16, 2009 03:24 PM | ENZN
- Enzon Announces Agreement to Sell Specialty Pharmaceutical Business
Nov 09, 2009 08:30 AM | ENZN
- Enzon's Debt is Reduced by $116 Million
Mar 08, 2010 09:51 AM | ENZN
- Immunomedics Appoints Kenneth J. Zuerblis to Board of Directors
Feb 10, 2010 09:52 AM | ENZN, IMMU
- Enzon Completes Sale of Specialty Pharmaceutical Business
Jan 29, 2010 04:53 PM | ENZN
- Enzon Sets Date of Special Meeting of Stockholders to Approve Sale of Specialty Pharmaceutical Business
Dec 22, 2009 03:53 PM | ENZN
- Enzon Board Authorizes Share Repurchase of up to $50 Million
Dec 03, 2009 09:53 AM | ENZN
- Enzon Reports 2nd Quarter 2009 Results
Aug 04, 2009 08:25 AM | ENZN
- CORRECTING and REPLACING Enzon to Present at BMO Focus on Healthcare Conference
Jul 28, 2009 09:34 AM | ENZN
- Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
Jul 27, 2009 01:01 PM | ENZN
- Enzon to Present at BMO Focus on Healthcare Conference
Jul 27, 2009 10:26 AM | ENZN
- DellaCamera Comments on Recent Replacement of Jeffrey H. Buchalter as Chairman of Enzon and Addition of New Independent Director to Enzon’s Board
Jul 23, 2009 04:46 PM | ENZN
- Form 4 ENZON PHARMACEUTICALS For: Feb 18 Filed by: Levy Harold J (10K)
Mar 10, 2010 02:29 PM
- Form 4 ENZON PHARMACEUTICALS For: Feb 24 Filed by: TOOMAN CRAIG A (10K)
Feb 26, 2010 05:30 PM
- Form 4 ENZON PHARMACEUTICALS For: Feb 22 Filed by: HORAK IVAN D (10K)
Feb 24, 2010 04:59 PM
- Form 4 ENZON PHARMACEUTICALS For: Jan 27 Filed by: TOOMAN CRAIG A (10K)
Jan 29, 2010 05:50 PM
- Form 4 ENZON PHARMACEUTICALS For: Jan 27 Filed by: del Campo Ralph (10K)
Jan 29, 2010 05:50 PM
- Form 4 ENZON PHARMACEUTICALS For: Jan 27 Filed by: Davit Paul Stephen (10K)
Jan 29, 2010 05:50 PM
- Form 4 ENZON PHARMACEUTICALS For: Jan 27 Filed by: HORAK IVAN D (10K)
Jan 29, 2010 05:49 PM
- Form 4 ENZON PHARMACEUTICALS For: Jan 27 Filed by: BUCHALTER JEFFREY H (10K)
Jan 29, 2010 05:49 PM
- Form 4 ENZON PHARMACEUTICALS For: Jan 17 Filed by: HORAK IVAN D (10K)
Jan 20, 2010 08:49 PM
- Form 4 ENZON PHARMACEUTICALS For: Jan 17 Filed by: del Campo Ralph (10K)
Jan 20, 2010 08:48 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
ENZN
|
Compare to S&P
|
| YTD |
-4.94 %
|
-7.82 %
|
| 4 Weeks |
9.64 %
|
2.54 %
|
| 12 Weeks |
-4.58 %
|
-8.52 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -0.01 %
|
|
EPS Growth in Last Year: 100.00 %
|
|
Sales Growth in Last Quarter: -0.92 %
|
|
Sales Growth in Last Quarter: -8.72 %
|
|
